Soc. Generale Call 40 GBF 21.06.2.../ DE000SV9QFK7 /
15.05.2024 14:24:05 | Изменение+0.190 | Бид15.05.2024 | Предложение15.05.2024 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.750EUR | +33.93% | 0.750 Величина цены спроса: 4,000 |
0.790 Величина цены предложения: 4,000 |
BILFINGER SE O.N. | 40.00 EUR | 21.06.2024 | Call |
GlobeNewswire
14:40
Thurgood Marshall College Fund added Denmark Technical College to its membership
GlobeNewswire
14:40
AITX Announces Its Breakthrough AIR™ (Autonomous Intelligent Response) Technology
GlobeNewswire
14:35
ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update
GlobeNewswire
14:32
Kartoon Studios Continues Execution of Growth Strategy With Profitability Targeted for Q2 2025; Prov...
GlobeNewswire
14:31
The Real Good Food Company to Participate in the 24th Annual B. Riley Institutional Investor Confere...
GlobeNewswire
14:30
Zhibao Technology Inc. Announces Closing of Underwriters’ Over-Allotment Option in Connection with I...
GlobeNewswire
14:30
Hudson Technologies to Attend 24th Annual B. Riley Securities Institutional Investor Conference
GlobeNewswire
14:30
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic C-Store Plans in Los Angeles with 7-Eleven
GlobeNewswire
14:30
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights fo...
GlobeNewswire
14:30
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the A...
GlobeNewswire
14:30
Reliance Global Group Announces Game-Changing Acquisition of Spetner Associates; Projected to Double...
GlobeNewswire
14:30
ALERUS FINANCIAL CORPORATION AND HMN FINANCIAL, INC. JOINTLY ANNOUNCE STRATEGIC TRANSACTION
GlobeNewswire
14:30
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
14:30
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
GlobeNewswire
14:30
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
14:30
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Tria...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница